aan het Rot, M, Collins, KA, Murrough, JW, Perez, AM, Reich, DL, Charney, DSet al.Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biol Psychiatry 2009;67(2):139–145.
Adler, CM, Malhotra, AK, Elman, I, Goldberg, T, Egan, M, Pickar, Det al.Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. Am J Psychiatry 1999;156(10):1646–1049.
Araya-Callís, C, Hiemke, C, Abumaria, N, Flugge, GChronic psychosocial stress and citalopram modulate the expression of the glian proteins GFAP and NDRG2 in the hippocampus. Psychopharmacology (Berl) 2012;224(1):209–222.
Autry, AE, Adachi, M, Nosyreva, E, Na, ES, Los, MF, Cheng, PFet al.NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 2011;475(7354):91–95.
Bergman, SAKetamine: review of its pharmacology and its use in pediatric anesthesia. Anesth Prog 1999;46(1):10–20.
Berman, RM, Cappiello, A, Anand, A, Oren, DA, Heninger, GR, Charney, DSet al.Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000;47(4):351–354.
Beurel, E, Song, L, Jope, RSInhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice. Mol Psychiatry 2011;16(11):1068–1070.
Browne, CA, Lucki, IAntidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants. Front Pharmacol 2013;4:161.
Chaviaras, S, Mak, P, Ralph, D, Krishnan, L, Broadbear, JHAssessing the antidepressant-like effects of carbetocin, an oxytocin agonist, using a modification of the forced swimming test. Psychopharmacology (Berl) 2010;210(1):35–43.
Cornwell, BR, Salvadore, G, Furey, M, Marquardt, CA, Brutsche, NE, Grillon, Cet al.Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression. Biol Psychiatry 2012;72(7):555–561.
de Oliveira, L, Fraga, DB, De Luca, RD, Canever, L, Ghedim, FV, Matos, MPet al.Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine. Metab Brain Dis 2011;26(1):69–77.
Garcia, LS, Comim, CM, Valvassori, SS, Réus, GZ, Stertz, L, Kapczinski, Fet al.Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats. Prog Neuropsychopharmacol Biol Psychiatry 2009;33(3):450–455.
Gigliucci, V, O’Dowd, G, Casey, S, Egan, D, Gibney, S, Harkin, AKetamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism. Psychopharmacology (Berl) 2013;228(1):157–166.
Huang, NK, Wan, FJ, Tseng, CJ, Tung, CSAmphetamine induces hydroxyl radical formation in the striatum of rats. Life Sci 1997;61(22):2219–2229.
Ibrahim, L, Diaz Granados, N, Jolkovsky, L, Brutsche, N, Luckenbaugh, DA, Herring, WJet al.A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder. J Clin Psychopharmacol 2012;32(4):551–557.
Judd, LL, Akiskal, HS, Schettler, PJ, Endicott, J, Maser, J, Solomon, DAet al.The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002;59(6):530–537.
Kim, H, Chen, L, Lim, G, Sung, B, Wang, S, McCabe, MFet al.Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression. J Clin Invest 2012;122(8):2940–2954.
Krishnan, V, Nestler, EJAnimal models of depression: molecular perspectives. Curr Top Behav Neurosci 2011;7:121–147.
Lapmanee, S, Charoenphandhu, J, Charoenphandhu, NBeneficial effects of fluoxetine, reboxetine, venlafaxine, and voluntary running exercise in stressed male rats with anxiety-and depression-like behaviors. Behav Brain Res 2013;250:316–325.
Li, N, Lee, B, Liu, RJ, Banasr, M, Dwyer, JM, Iwata, Met al.mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010;329(5994):959–964.
Li, N, Liu, RJ, Dwyer, JM, Banasr, M, Lee, B, Son, Het al.Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry 2011;69(8):754–761.
Liu, Q, Yu, J, Mao-Ying, QL, Mi, WL, Li, B, Wang, YQet al.Repeated clomipramine treatment reversed the inhibition of cell proliferation in adult hippocampus induced bychronic unpredictable stress. Pharmacogenomics J 2008;8(6):375–383.
Ma, XC, Dang, YH, Jia, M, Ma, R, Wang, F, Wu, Jet al.Long-lasting antidepressant action of ketamine, but not glycogen synthase kinase-3 inhibitor SB216763, in the chronic mild stress model of mice. PLoS One 2013;8(2):e56053.
Maeng, S, Zarate, CA Jr., Du, J, Schloesser, RJ, McCammon, J, Chen, Get al.Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry 2008;63(4):349–352.
Monteggia, LM, Gideons, E, Kavalali, ETThe role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine. Biol Psychiatry 2013;73(12):1199–1203.
Murrough, JW, Iosifescu, DV, Chang, LC, Al Jurdi, RK, Green, CE, Perez, AMet al.Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry 2013;170(10):1134–1142.
Murrough, JW, Perez, AM, Pillemer, S, Stern, J, Parides, MK, aan het Rot, Met al.Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry 2013;74(4):250–256.
Nakajima, S, Suzuki, T, Watanabe, K, Kashima, H, Uchida, HAccelerating response to antidepressant treatment in depression: a review and clinical suggestions. Prog Neuropsychopharmacol Biol Psychiatry 2010;34(2):259–264.
Nishitani, N, Nagayasu, K, Asaoka, N, Yamashiro, M, Shirakawa, H, Nakagawa, Tet al.Raphe AMPA receptors and nicotinic acetylcholine receptors mediate ketamine-induced serotonin release in the rat prefrontal cortex. Int J Neuropsychopharmacol 2014;17(8):1321–1326.
Owolabi, RA, Akanmu, MA, Adeyemi, OIEffects of ketamine and N-methyl-d-aspartate on fluoxetine-induced antidepressant-related behavior using the forced swimming test. Neurosci Lett 2014;566:172–176.
Parise, EM, Alcantara, LF, Warren, BL, Wright, KN, Hadad, R, Sial, OKet al.Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats. Biol Psychiatry 2013;74(10):750–759.
Perry, EB Jr., Cramer, JA, Cho, HS, Petrakis, IL, Karper, LP, Genovese, Aet al.Psychiatric safety of ketamine in psychopharmacology research. Psychopharmacology 2007;192(2):253–260.
Preskorn, SH, Baker, B, Kolluri, S, Menniti, FS, Krams, M, Landen, JWAn innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist. CP-101,606, in patients ithtreatment-refractory majord epressive disorder. J Clin Psychopharmacol 2008;28(6):631–637.
Rushforth, SL, Steckler, T, Shoaib, MNicotine improves working memory span capacity in rats following sub-chronic ketamine exposure. Neuropsychopharmacology 2011;36(13):2774–2781.
Shiroma, PR, Johns, B, Kuskowski, M, Wels, J, Thuras, P, Albott, CSet al.Augmentation of response and remission to serial intravenous; subanesthetic ketamine in treatment resistant depression. J Affect Disord 2014;155:123–129.
Skolnick, P, Popik, P, Trullas, RGlutamate-based antidepressants: 20 years on. Trends Pharmacol Sci 2009;30(11):563–569.
Szymkowicz, SM, Finnegan, N, DaleR, MA 12-month naturalistic observation of three patients receiving repeat intravenous ketamine infusions for their treatment-resistant depression. J Affect Disord 2013;147(1–3):416–420.
Thase, ME, Haight, BR, Richard, N, Rockett, CB, Mitton, M, Modell, JGet al.Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. J Clin Psychiatry 2005;66(8):974–981.
Tokita, K, Yamaji, T, Hashimoto, KRoles of glutamate signaling in preclinical and/or mechanistic models of depression. Pharmacol Biochem Behav 2012;100(4):688–704.
Tomiya, M, Fukushima, T, Kawai, J, Aoyama, C, Mitsuhashi, S, Santa, Tet al.Alterations of plasma and cerebrospinal fluid glutamate levels in rats treated with the N-methyl-D-aspartate receptor antagonist, ketamine. Biomed Chromatogr 2006;20(6–7):628–633.
Trivedi, MH, Rush, AJ, Wisniewski, SR, Nierenberg, AA, Warden, D, Ritz, Let al.Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006;163(1):28–40.
Wang, X, Yang, Y, Zhou, X, Wu, J, Li, J, Jiang, Xet al.Propofol pretreatment increases antidepressant-like effects induced by acute administration of ketamine in rats receiving forced swimming test. Psychiatry Res 2011;185(1–2):248–253.
Yang, J, Pei, Y, Pan, YL, Jia, J, Shi, C, Yu, Yet al.Enhanced antidepressant-like effects of electroacupuncture combined with citalopram in a rat model of depression. Evid Based Complement Alternat Med 2013;2013:107380.
Zarate, CA Jr., Singh, JB, Carlson, PJ, Brutsche, NE, Ameli, R, Luckenbaugh, Aet al.A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006;63(8):856–864.
Zarate, CA Jr., Brutsche, NE, Ibrahim, L, Franco-Chaves, J, Diazgranados, N, Cravchik, Aet al.Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry 2012;71(11):939–946.
Zhang, GF, Wang, N, Shi, JY, Xu, SX, Li, XM, Ji, MHet al.Inhibition of L-arginine-nitric oxide pathway mediates the antidepressant effects of ketamine on rats in the forced swimming test. Pharmacol Biochem Behav 2013;110:8–12.
Zhou, Z, Zhang, G, Li, X, Liu, X, Wang, N, Qiu, Let al.Loss of phenotype of parvalbumin interneurons in rat prefrontal cortex is involved in antidepressant- and propsychotic-like behaviors following acute and repeated ketamine administration. Mol Neurobiol 2014 [Epub ahead of print].
Zuo, DY, Wu, YL, Yao, WX, Cao, Y, Wu, CF, Tanaka, MEffect of MK-801 and ketamine on hydroxyl radical generation in the posterior cingulate and retrosplenial cortex of free-moving mice, as determined by in vivo microdialysis. Pharmacol Biochem Behav 2007;86(1):1–7.